Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:10 AM UTC
| NCT Number | NCT04588922 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Sellas Life Sciences Group |
| Last Updated on CT.gov | July 16, 2025 (Jul 16, 2025) |
As of March 2, 2026: Clinical trial NCT04588922 is currently recruiting participants. This clinical trial study for acute myeloid leukemia is actively seeking new participants at 8 locations across the United States. The study is sponsored by Sellas Life Sciences Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04588922 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04588922 was last updated Jul 16, 2025 (July 16, 2025). HelloStudys verifies this status automatically.